Molecular Discovery

Molecular Discovery
Molecular Discovery Ltd
Type Ltd
Industry Life sciences
Founded 1984
Founder(s) Prof. Peter Goodford
Headquarters London
Key people Prof. Gabriele Cruciani
Website www.moldiscovery.com

Molecular Discovery Ltd is a software company working in the area of drug discovery.

Founded in 1984 by Peter Goodford, its aim was to provide the GRID[1] software to scientists working in the field of Drug Design, and enabled one of the first examples of rational drug design[2] with the discovery of Zanamivir in 1989. In combination with statistical methods such as GOLPE, GRID molecular interaction fields can also be used to perform 3D-QSAR.

In the last decade, the GRID forcefield has been applied to other areas of Drug Discovery, including virtual screening, scaffold-hopping, ADME and pharmacokinetic modelling, optimisation of metabolic stability and metabolite prediction, as well as pKa and tautomer modelling.

Molecular Discovery manages a Cytochrome P450 Consortium aimed at generating a large set of homogeneous experimental data for human metabolism, allowing the development of predictive in silico models.[3]

Products

  • GRID, a program for rational or structure-based design using molecular interaction fields
  • MetaSite, a program for predicting metabolic "hotspots" or "soft spots" and subsequent metabolite formation
  • VolSurf+, a program for modelling pharmacokinetic or ADME properties
  • SHOP, a program for scaffold replacement
  • MoKa, a program for modelling pKa and tautomerisation
  • Almond, a program for 3D-QSAR

References

  1. ^ Goodford, P.J. (1985) A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. Med. Chem., 28, 849-857
  2. ^ Von Itzstein, M. et al. (1993) Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature, 363, 418-423
  3. ^ Cytochrome P450 Consortium

External links


Wikimedia Foundation. 2010.

Игры ⚽ Нужен реферат?

Look at other dictionaries:

  • Discovery and development of nucleoside and nucleotide reverse-transcriptase inhibitors — (NRTIs and NtRTIs) began in the 1980s when the AIDS epidemic hit Western societies. NRTIs inhibit the reverse transcriptase (RT), an enzyme that controls the replication of the genetic material of the human immunodeficiency virus (HIV). The first …   Wikipedia

  • Molecular Devices — Type Subsidiary Industry R D Headquarters Sunnyva …   Wikipedia

  • Molecular gastronomy — includes the study of how different cooking temperatures affect eggs,[1][2] and their viscosity, their surface tension, and different ways of introducing air into them …   Wikipedia

  • Molecular Informatics —   Titre abrégé Mol. Inf. Discipline Chimie Langue …   Wikipédia en Français

  • Molecular mimicry — is defined as the theoretical possibility that sequence similarities between foreign and self peptides are sufficient to result in the cross activation of autoreactive T or B cells by pathogen derived peptides. Despite the promiscuity of several… …   Wikipedia

  • Molecular Pharmaceutics —   Titre abrégé Mol. Pharm. Discipline Chimie Langue …   Wikipédia en Français

  • Molecular engineering — is any means of manufacturing molecules. It may be used to create, on an extremely small scale, most typically one at a time, new molecules which may not exist in nature, or be stable beyond a very narrow range of conditions. Today this is an… …   Wikipedia

  • Discovery Net — is one of the earliest examples of a scientific workflow system allowing users to coordinate the execution of remote services based on Web service and Grid Services (OGSA and Open Grid Services Architecture) standards. The system was designed and …   Wikipedia

  • Molecular Systems Biology —   Abbreviated title (ISO) Mol. Syst. Biol. Discipline Systems biology …   Wikipedia

  • Molecular Diversity —   Discipline Biochemistry Language English …   Wikipedia

Share the article and excerpts

Direct link
… Do a right-click on the link above
and select “Copy Link”